IPVision in the News

Current Articles | RSS Feed RSS Feed

Patent Perspectives: On Security - From Technology Review & IPVision


Technology Review's July - August issue includes a briefing on information security. In developing their analysis, IPVision supported Technology Review's editors with patent and intellectual property analysis on the security sector. 

In addition to the core Technology Review briefing, we provide a supplemental analysis of key IP positions in the field for 20 companies deserving attention of corporate leadership, experts, and technology investors.

Download the free: Patent Perspectives: On Security supplemental report.

Patent Perspectives: On Security - IPVision Patent Analysis and Technology Review

This report includes IPVision's patent portfolio assessments of 20 companies to watch, including such firms as Google, Facebook, Verdasys, Symantec, and McAFee. Highly rated patent positions include both public and private firms -- while several key innovators score poorly. A potentially troubling signal for their investors and management.

In addition, given their critical role in the industry, IPVision provides additional insights into the patent competition between Symantec and McAfee.

The report provides "must read" insights and provokes questions for leaders in the field as they grapple with day to day decisions related to their R&D and innovation investments and consider corporate strategy and patent risk profiles.  For example, how did Symantec create its position relative to McAfee, or how what are Google and Facebook management doing with their "patent levers" within their broader corporate strategy?

Download the report and let us know your thoughts.


Patent Analysis supports Lemelson-MIT Prize Award to Carolyn Bertozzi


Carolyn Bertozzi of the UC-Berkeley Department of Chemistry

On June 2, 2010, the Lemelson-MIT Program announced that Carolyn Bertozzi of the UC-Berkeley Department of Chemistry is the 2010 Winner of the $500,000 Lemelson-MIT Prize.

This year's evaluation process incorporated structured discussions of the patents held by each nominee. IPVision supported the process by contributing patent analysis reports on the nominees' patents.

Learn more about Carolyn Bertozzi's patents and the patent analysis supplied by IPVision to the Lemelson-MIT Program in the IPVisions blog.  

Given the societal benefits gained through experimentation, inventive activity, innovation and disclosure incented through the patenting system, the Lemelson-MIT Program authorized IPVision to release its report to the public. The patent analysis report is available for download here


Patent Metrics & IP Strategy for Early-Stage Investors Expert Panel


Patent metrics and IP strategy for early-stage and growth stage companies are the topics of discussion on May 21st at a panel moderated by IPVision's Alex Butler during the upcoming Licensing Executives Society (LES) Spring Meeting in Boston on May 21.

IP in early-stage commercial and investment success: IAM  MagazineThe panel will include multiple perspectives of how serial entrepreneurs, investors, and management assess when and how to craft their IP strategies and the signals that those strategies provide to future results. IPVision's published article on the correlation between high quality patent positions and successful exit in Intellectual Asset Management Magazine (as a proxy for investment success) provides additional information on how IP can provide a leading indicator of management's ability to deliver value.

Investors and technology experts intuitively 'know' that developing a proactive IP strategy and efficiently and cost-effectively understanding the patent landscape within their industry inform critical decisions across a spectrum of activities, including considering investments, alliance discussions and the important choices of what to patent, or disclose, as they commercialize technologies.

Moving from this known need to demonstrably incorporating an IP perspective into product development, innovation processes, and crafting protected freedom to operate is a critical skill. Developing and observing well-positioned, high-quality IP positions is one measurable indicator of this skill.

Increasingly, management and investors are leveraging key indicators and patent benchmarks of other successful firms and past investments, to help inform strategies and tactics. If used appropriately, these same measurements can provide important signals to how successfully companies and management teams are including an understanding of intellectual property rights within their business processes.

The LES Spring Meeting (http://lesusacanada.org) focuses upon the topics of innovation, entrepreneurship and technology commercialization and will bring together more than 400 technology executives, intellectual property experts and technology transfer leaders.


Multicore Patent Landscape Supports Technology Review Briefing


Patent landscape analysis by IPVision contributes to understanding role of patent rights in investment and development of microprocessor and multicore processor technologies.

IPVision patent analysis supports Technology Review (May/June 2010) briefing on microprocessors.

Patent map of NTT multicore processor patent - IPVision

The full Technology Review briefing contents include:

  • Technology Overview: Designing for Mobility
  • Companies to Watch 
  • Industry Challenges: The High Cost of Upholding Moore's Law
  • Case Study: Printing a Path to Success
  • Over the Horizon: Computing Beyond Silicon
  • China: A New Processor for a New Market
  • Intellectual Property: Multicore Patents
  • Timeline: March of the Machines
  • Market Watch: Mobile chips threaten high-performance manufacturers
  • Research to Watch: Multicore processors create software headache
Please let us know if you are interested in learning more about the microprocessor or multicore technology and patent landscape.


Importance of IP to Early-Stage Success | IPVision in IAM Magazine


The importance of patent quality and patent strategy are explored in the March/April Issue of IAM Magazine in "Measured for Success: IP in Early-Stage Commercial and Investment Success"

Download Article Reprint

Patent Assessments and Patent Ratings for VC backed companies in healthcare sector - IPVisionIn the article, Joe Hadzima, Bruce Bockmann and Alex Butler of the IPVision leadership team provide findings on how evidence-based approaches to intellectual property decisions can generate immediate and lasting value for early-stage and growth companies and their investors.


"Startups and Patents . . Really?"


Patent strategy research by IPVision focus of "Startups and Patents..Really?" by Mark Barry of venture capital firm Open View Venture Partners.

Patent Strategy: "Action Plan: Your 2010 Performance Review"


In the March/April Issue of IAM Magazine, Alex Butler and Joseph Hadzima provide perspectives to the author, Joe Jennings, on how organizations can respond to near-term economic pressures and identify IP strategies to drive corporate performance in 2010 and beyond.

The article is available to subscribers of IAM Magazine.


Innovation: "MarketWatch: Sequencing Companies Dominate Investment"


Insights into innovations and patent strategy in the field of personalized medicine provided to Technology Review (March / April 2010)

IP Strategist Cites Value of IPVision Patent Portfolio Assessments


IPVision's research on the correlation of patent quality and IP strategy to corporate success highlighted by Jackie Hutter, a patent strategist, in the IP Asset Maximizer Blog.

Download a copy of the noted article:  "Measured for Success: IP in Early-Stage Commercial and Investment Success" (IAM Magazine, March/April 2010) IP in early-stage success


Innovation: Why does it take so long to commercialize technologies


Microfluidics is an example of important innovations and entrepreneurial efforts. Technology Review addresses the adoption cycle for such innovations and draws upon IPVision's patent analysis in exploring this issue. Technology Review "Shoveling Water: Why does it take so long to commercialize new technologies?" (January 2010)

All Posts